ɬÀï·¬

News

Creating a molecular map
for the plant sciences

The first comprehensive map of the proteome of the model plant Arabidopsis thaliana
Bernhard Küster
By Bernhard Küster
March 27, 2020

Plants are essential for life on earth. They provide food for virtually all organisms and oxygen for breathing, and they regulate the climate of the planet. Proteins play a key role in controlling all aspects of life including plants. Under the leadership of the Technical University of Munich, or TUM, our team of scientists has now mapped about 18,000 of the proteins found in the model plant Arabidopsis thaliana.

Bernhard Kuster/TUM
By mapping more than 18,000 proteins, TUM scientists have created an extensive molecular reference for the popular model plant Arabidopsis thaliana, which is freely accessible via the online database ProteomicsDB.

Every cell of any organism contains the complete genetic information, or the blueprint, of a living being, encoded in the sequence of the so-called nucleotide building blocks of DNA. But how does a plant create tissues as diverse as a leaf that converts light into chemical energy and produces oxygen, or a root that absorbs nutrients from the soil?

The answer lies in the protein pattern of the cells of the respective tissue. Proteins are the main molecular players in every cell. They are biocatalysts, transmit signals inside and between cells, form the structure of a cell and much more.

To form the protein pattern, it is not only important which proteins are present in a tissue but, more importantly, in what quantities. For example, proteins of the photosynthesis machinery are found primarily in leaves but also in seeds, yet at a thousand times lower levels.

Laboratory plants as a model for basic research

Our team, led by postdoc Julia Mergner, examined the model plant Arabidopsis thaliana, or thale cress, using biochemical and analytical high-throughput methods to find out more about its molecular composition.

For 40 years, this rather inconspicuous weed with small white flowers has been the laboratory mouse of plant biology. It is small, generally undemanding and easy to grow. These properties have paved the way for its frequent use in genetics and molecular biology. Insights from basic research on Arabidopsis can often be transferred to crop plants, making it interesting for plant-breeding research.

Most of the data were generated using a method called liquid chromatography–tandem mass spectrometry, which enables the analysis of thousands of proteins in parallel in one experiment; bioinformatics methods helped analyze the huge amounts of data. The in the journal Nature.

An atlas for the global scientific community

For the first time, we have comprehensively mapped the proteome, that is, all proteins from the tissues of the model plant Arabidopsis. This allows new insights into the complex biology of plants.

All results of the research are summarized in a virtual atlas, which provides initial answers to the questions:

  • How many of the approximately 27,000 genes exist in the plant as proteins (> 18,000)?
  • Where are they located within the organism (e.g., flower, leaf or stem)?
  • In what approximate quantities do they occur?

All data is freely available in the online database , which already contains a protein catalog for the human proteome, which our team at TUM decoded in 2014.

One can anticipate similarities between Arabidopsis and the molecular maps of other plants. The atlas should, therefore, also inspire research on other plants.

In the future, we will turn our attention to the analysis of crops. Of particular interest will be investigating how the proteome changes when plants are attacked by pests or how plants can adapt to climate change.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Bernhard Küster
Bernhard Küster

Bernhard Küster is the chair of proteomics and bioanalytics at the Technical University of Munich and an associate editor of the journal Molecular & Cellular Proteomics.
 

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

What’s in a diagnosis?
Essay

What’s in a diagnosis?

Sept. 4, 2025

When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.

Peer through a window to the future of science
Annual Meeting

Peer through a window to the future of science

Sept. 3, 2025

Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Glow-based assay sheds light on disease-causing mutations
Journal News

Glow-based assay sheds light on disease-causing mutations

Sept. 2, 2025

University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent ɬÀï·¬ paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent ɬÀï·¬ paper.

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.